Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (261-270 of 290) with videos related to

Pageof 29
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
Mycoses|April 28, 2018
Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosisAlireza Abdolrasouli, Amelia C Bercusson, Johanna L Rhodes, et al.
The European Respiratory Journal|January 19, 2019
Targeting of cathepsin S reduces cystic fibrosis-like lung diseaseDonna M Small, Ryan R Brown, Declan F Doherty, et al.
Physiological Genomics|December 24, 2009
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityRebecca Darrah, Edward McKone, Clare O'Connor, et al.
The European Respiratory Journal|July 15, 2017
Characterisation of eppin function: expression and activity in the lungAaron Scott, Arlene Glasgow, Donna Small, et al.
The European Respiratory Journal|June 28, 2018
Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite studyMarianne S Muhlebach, Joseph E Hatch, Gisli G Einarsson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2013
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungsGerd Döring, Alessandra Bragonzi, Moira Paroni, et al.
The New England Journal of Medicine|November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
The New England Journal of Medicine|May 19, 2015
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTRClaire E Wainwright, J Stuart Elborn, Bonnie W Ramsey, et al.
ERJ Open Research|October 21, 2020
Multiple breath washout in bronchiectasis clinical trials: is it feasible?Katherine O'Neill, Kathryn Ferguson, Denis Cosgrove, et al.
Pageof 29

Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
Mycoses|April 28, 2018
Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosisAlireza Abdolrasouli, Amelia C Bercusson, Johanna L Rhodes, et al.
The European Respiratory Journal|January 19, 2019
Targeting of cathepsin S reduces cystic fibrosis-like lung diseaseDonna M Small, Ryan R Brown, Declan F Doherty, et al.
Physiological Genomics|December 24, 2009
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityRebecca Darrah, Edward McKone, Clare O'Connor, et al.
The European Respiratory Journal|July 15, 2017
Characterisation of eppin function: expression and activity in the lungAaron Scott, Arlene Glasgow, Donna Small, et al.
The European Respiratory Journal|June 28, 2018
Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite studyMarianne S Muhlebach, Joseph E Hatch, Gisli G Einarsson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2013
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungsGerd Döring, Alessandra Bragonzi, Moira Paroni, et al.
The New England Journal of Medicine|November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
The New England Journal of Medicine|May 19, 2015
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTRClaire E Wainwright, J Stuart Elborn, Bonnie W Ramsey, et al.
ERJ Open Research|October 21, 2020
Multiple breath washout in bronchiectasis clinical trials: is it feasible?Katherine O'Neill, Kathryn Ferguson, Denis Cosgrove, et al.
Pageof 29